Brand Name | Status | Last Update |
---|---|---|
abecma | Biologic Licensing Application | 2024-01-04 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
multiple myeloma | — | D009101 | C90.0 |
Expiration | Code | ||
---|---|---|---|
idecabtagene vicleucel, Abecma, Celgene Corporation, a Bristol-Myers Squibb Company | |||
2028-03-26 | Orphan excl. |
Code | Description |
---|---|
Q2055 | Idecabtagene vicleucel, up to 460 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Multiple myeloma | D009101 | — | C90.0 | 38 | 23 | 6 | 1 | 5 | 62 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 2 | 1 | — | — | — | 2 |
Plasma cell leukemia | D007952 | — | C90.1 | — | 2 | — | — | — | 2 |
Leukemia | D007938 | — | C95 | 1 | 1 | — | — | — | 1 |
Lymphoma | D008223 | — | C85.9 | 1 | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Glycogen storage disease type ii | D006009 | Orphanet_365 | E74.02 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | — | — | — | — | 1 | 1 |
B-cell lymphoma | D016393 | — | — | — | — | — | — | 1 | 1 |
Drug common name | Idecabtagene vicleucel |
INN | idecabtagene vicleucel |
Description | Idecabtagene vicleucel, sold under the brand name Abecma, is a cell-based gene therapy to treat multiple myeloma.
|
Classification | Gene |
Drug class | Antineoplastic |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL4298199 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | 8PX1X7UG4D (ChemIDplus, GSRS) |